E-Books durchsuchen

Biopharmaceutical Production Technology [2012]

1
Strategies for Plasmid DNA Production in <fi>Escherichia coli</fi>
43
Advances in Protein Production Technologies
79
Releasing Biopharmaceutical Products from Cells
107
Continuous Chromatography (Multicolumn Countercurrent Solvent Gradient Purification) for Protein Purification
139
Virus‐Like Particle Bioprocessing
165
Therapeutic Protein Stability and Formulation
199
Production of PEGylated Proteins
223
Affinity Chromatography: Historical and Prospective Overview
283
Hydroxyapatite in Bioprocessing
333
Monoliths in Bioprocessing
377
Membrane Chromatography for Biopharmaceutical Manufacturing
409
Modeling and Experimental Model Parameter Determination with Quality by Design for Bioprocesses
445
Biosensors in the Processing and Analysis of Biopharmaceuticals
473
Proteomics Toolkit: Applications in Protein Biological Production and Method Development
489
Science of Proteomics: Historical Perspectives and Possible Role in Human Healthcare
511
Consistency of Scale‐Up from Bioprocess Development to Production
545
Systematic Approach to Optimization and Comparability of Biopharmaceutical Glycosylation Throughout the Drug Life Cycle
585
Quality and Risk Management in Ensuring the Virus Safety of Biopharmaceuticals
613
Ensuring Quality and Efficiency of Bioprocesses by the Tailored Application of Process Analytical Technology and Quality by Design
657
Bioprocess Design and Production Technology for the Future
707
Integrated Process Design: Characterization of Process and Product Definition of Design Spaces
717
Evaluating and Visualizing the Cost‐Effectiveness and Robustness of Biopharmaceutical Manufacturing Strategies
743
Full Plastics: Consequent Evolution in Pharmaceutical Biomanufacturing from Vial to Warehouse
769
BioSMB™ Technology: Continuous Countercurrent Chromatography Enabling a Fully Disposable Process
793
Single‐Use Technology: Opportunities in Biopharmaceutical Processes
817
Single‐Use Biotechnologies and Modular Manufacturing Environments Invite Paradigm Shifts in Bioprocess Development and Biopharmaceutical Manufacturing
859
Index
I
Front Matter
Feedback